Stockreport

Truist Hikes Centessa (CNTA) PT to $33 While Maintaining Consistent 2026 Thesis [Yahoo! Finance]

Centessa Pharmaceuticals plc - American Depositary Shares  (CNTA) 
PDF firm's price target on Centessa to $33 from $30, while keeping a Buy rating on the shares. This decision was made as Truist updated its model, but noted that the company [Read more]